XEOS Announces Publication of Landmark BrIMA Study in JAMA Surgery Demonstrating Significant Improvement in Intraoperative Margin Assessment with Specimen PET-CT

Contributed by: PR Newswire

Tags

XEOS-BrIMA-Study

More Like This

PR Newswire associated0

ClearCut Medical Announces Results of a Post Marketing ClearCoast™ Study Presented at the San Antonio Breast Cancer Symposium

PR Newswire associated0

New data indicates use of 3D specimen tomosynthesis can improve breast cancer surgical outcomes

United Imaging Healthcare debuts Next-Generation PET/CT Systems, the uMI Panorama Family, and the Integrated Molecular Technology Platform at EANM

Vara receives CE mark for tomosynthesis AI - extending Europe’s leading screening-grade AI portfolio to 3D

PR Newswire associated0

New technology aiming to improve patients' outcomes in breast cancer

PR Newswire associated0

Sirius Medical collaborates with GE Healthcare to showcase the Pintuition® and CEM combination for an efficient and accurate breast cancer care pathway

PR Newswire associated0

Mammotome Launches First In-Room MR Vacuum-Assisted Breast Biopsy System

Dr. Mariana-Felicia Sandor, first author of the SHIELD study: Reoperation Rate in Breast-Conserving Surgery using Confocal Histolog® Scanner for Intraoperative Tissue Assessment, performs real-time, high-resolution tissue assessments during breast-conserving surgery (BCS) using the FDA-cleared Histolog Scanner. SHIELD study data indicates the innovative imaging device reduced reoperation rates during BCS from 30% to 10%, representing a 67% reduction. (Photo: Business Wire)

SamanTree Medical Highlights Research Showing 67% Reduction in Reoperation Rates for Breast-Conserving Surgery at the 2024 SABCS